Abbott's Surprising Surge: What's Behind the Medical Giant's Boosted Outlook?
The medical device and pharmaceutical giant Abbott Laboratories has seen its stock rise to a three month high after releasing an unexpectedly robust second quarter earnings report.
The company's decision to revise its full year profit forecast upward sent investors scrambling, with shares increasing 14% in the aftermath.